Your Location：
Home >
Browse articles >
Xiao Chaihutang Combined with Erchen Tang Ameliorates Metabolic-associated Fatty Liver Disease in Mice by Regulating SIRT1/PGC-1α/PPARα Signaling Pathway
Updated：2026-09-07
Previous|Next

    • Xiao Chaihutang Combined with Erchen Tang Ameliorates Metabolic-associated Fatty Liver Disease in Mice by Regulating SIRT1/PGC-1α/PPARα Signaling Pathway

      Enhanced Publication
    • “Xiaochaihu Tang combined with Erchen Tang can improve metabolic related fatty liver disease in mice, and its mechanism is related to the activation of the SIRT1/PGC-1 α/PPAR α signaling pathway, providing new ideas for traditional Chinese medicine prevention and treatment of this disease.”
    • LIU Kai , ZHANG Chenfang , FAN Chaowen , YAO Qiuyue , KE Zunli
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 18, Pages: 69-76(2026)

    • DOI： 10.13422/j.cnki.syfjx.20252504     

      CLC：

    • Revised：2025-12-23 ，

      Accepted：24 December 2025 ，

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 3 ) Tabs( 6 )

  • References

  • Publication Info

  • Metrics

136

Views

46

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Shaoyao Gancaotang Alleviates High-fat Diet-aggravated Colitis in Mice by Suppressing Ferroptosis Through SLC7A11/GPX4 Signaling Pathway
Danshen Zexie Decoction Alleviates Mitochondrial Dysfunction in Rat Model of MAFLD by Intervening in Mitophagy via PINK1/Parkin Signaling Pathway
Regulatory Effect of Danshen Zexie Decoction on Gut Microbiota-SCFAs-GLP-1 Metabolic Axis in Rat Model of Metabolic-associated Fatty Liver Disease
Danshen Zexie Decoction Ameliorates Metabolic-associated Fatty Liver Disease with Liver Fibrosis by Regulating Glycolysis and Inhibiting NETs
Effect and Mechanism of Modified Sini San on Improving Intestinal Mucosal Barrier of Chronic Stress Rats via Regulating Short-chain Fatty Acid Metabolism and Inhibiting HMGB1/RAGE Signaling Pathway

Related Author

SHI Juan
GAO Lianyin
ZHANG Xiaohui
JI Jing
MA Chongyang
WANG Xueqian
CHENG Fafeng
XU Tian

Related Institution

Peking Union Medical College Hospital， Chinese Academy of Medical Sciences
School of Traditional Chinese Medicine， Beijing University of Chinese Medicine
School of Integrated Chinese and Western Medicine， Anhui University of Chinese Medicine
School of Traditional Chinese Medicine， Capital Medical University
The First Affiliated Hospital of Hebei University of Chinese Medicine